Diamedica TherapeuticsDMAC
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 40 institutions reported holding Diamedica Therapeutics Inc. (DMAC) in their 13F filings, up 8 from Q2 2024. 12 opened new positions and 4 sold out. The largest holders were Omega Advisors (Leon Cooperman) ($6.3M), Vanguard Group Inc. ($4.4M) and First Manhattan Co. Llc. ($3.5M). 3 famous investors held it, including Leon Cooperman (0.3% of Omega Advisors (Leon Cooperman)'s portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Diamedica Therapeutics Inc.
- CUSIP
- 25253X207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $862K |
| Exits | 4 | $359K |
All 13F filers, Q2 2024 → Q3 2024: 641,989 shares bought and 127,208 shares sold, net +514,781 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Omega Advisors (Leon Cooperman) | 0.27% | Add +8.0% | 1,511,739 | $6.3M |
| Vanguard Group Inc. | 0.00% | Add +3.1% | 1,049,029 | $4.4M |
| First Manhattan Co. Llc. | 0.01% | No change | 839,081 | $3.5M |
| Paragon Associates & Paragon Associates II Joint Venture | 3.63% | No change | 482,614 | $2.0M |
| Bleichroeder LP | 0.43% | No change | 382,317 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +29.6% | 306,958 | $1.3M |
| LPL Financial LLC | 0.00% | Add +702.9% | 140,500 | $589K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 120,290 | $504K |
| Morgan Stanley | 0.00% | Add +27.6% | 110,016 | $461K |
| BlackRock, Inc. | 0.00% | — | 107,790 | $452K |
| Susquehanna International Group, LLP | 0.00% | Add +133.9% | 101,450 | $425K |
| State Street Corp. | 0.00% | No change | 68,729 | $288K |
| Qube Research & Technologies Ltd | 0.00% | New | 52,089 | $218K |
| Catalyst Financial Partners LLC | 0.03% | No change | 38,457 | $161K |
| Millennium Management | 0.00% | New | 33,690 | $141K |
| Blue Trust, Inc. | 0.00% | New | 44,247 | $131K |
| Jefferies Financial Group Inc. | 0.00% | New | 26,000 | $109K |
| Citigroup Inc. | 0.00% | New | 22,097 | $93K |
| Stonebridge Capital Advisors LLC | 0.01% | Reduce -12.5% | 17,500 | $73K |
| Dimensional Fund Advisors LP | 0.00% | No change | 16,959 | $71K |
| BNP Paribas Financial Markets | 0.00% | Add +8.6% | 16,500 | $69K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,251 | $56K |
| UBS Group AG | 0.00% | New | 12,739 | $53K |
| Citadel Advisors | 0.00% | Add +40.6% | 11,831 | $50K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | New | 11,520 | $48K |
| Magnolia Capital Advisors LLC | 0.02% | No change | 10,000 | $42K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 9,498 | $40K |
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 4,824 | $20K |
| US Bancorp \de | 0.00% | No change | 4,335 | $18K |
| Simplex Trading, LLC | 0.00% | New | 3,662 | $15K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 3,263 | $14K |
| Naples Money Management LLC | 0.01% | Reduce -30.6% | 2,068 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -40.8% | 1,118 | $5K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1,070 | $4K |
| Osaic Holdings, Inc. | 0.00% | Reduce -48.7% | 1,055 | $4K |
| Legend Financial Advisors, Inc. | 0.00% | No change | 1,000 | $4K |
| Royal Bank of Canada | 0.00% | Reduce -23.8% | 805 | $3K |
| Bank of America Corp. | 0.00% | Add +16.4% | 213 | $892 |
| Cornerstone Planning Group LLC | 0.00% | New | 80 | $346 |
| JPMorgan Chase & Co. | 0.00% | New | 27 | $113 |
"% of holder's portfolio" is DMAC's weight in each manager's 13F, not the share of Diamedica Therapeutics Inc. the manager owns.